IP Library › Granted Patent US 10,369,235
Granted Patent B2
US 10,369,235 · App. 15/422,129 · Granted Aug 6, 2019

Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof

Inventors: Yong Hoon Chung (Seoul, KR); Hyun Sub Lee (Seoul, KR)
Assignee: MEDEXGEN INCORPORATED
A61K49/0004A61K38/4893A61K49/00C12N9/52C12Y304/24069G01N30/96
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,235
App. No.
15/422,129
Granted
Aug 6, 2019
Kind
B2
Abstract

The present invention relates to a method for purifying a non-spreading botulinum toxin that causes local muscle paralysis and a non-spreading botulinum toxin obtained thereby. The method comprises the steps of: subjecting a purified botulinum toxin type A product to ion-exchange chromatography using a controlled pH of buffer, concentration of sodium chloride (NaCl), thereby separating the botulinum toxin type A product into subfractions; and collecting a subfraction having an A260/A280 value in a specific range from the separated subfractions.

Claims (10)

1. A method for determining a non-spreading botulinum toxin, comprising:

injecting the non-spreading botulinum toxin into the either left or right hind limb calf muscle of mouse (4-6 wk old, weighing 18-22 g) in an amount equivalent to 1.5-3 times the LD50 of the toxin in the volume ranges of 20-50 μL; and

assessing paralysis conditions of the hind limb muscles and respiratory muscles of the injected mouse and a survival rate of the injected mouse to determine a non-spreading botulinum toxin.

2. The method of claim 1 , wherein the non-spreading botulinum toxin shows a survival rate at least 80 % at 96 hours after injection of 2 U toxin preparation in the volume 50 μL either left or right hind limb calf muscle of the mouse.

3. The method of claim 2 , wherein the paralysis conditions comprises:

limb appearance and walking of normal mice;

mice walk with dragging, but toes are not put together;

mice walk with dragging, toes are put together;

mice walk with dragging, toes are put together, foot joints are bent inward; and

mice walk with dragging, toes are put together, foot joints are bent inward, feet come into contact with leg muscles, and legs are lame.

Priority Claims (1)
KR 10-2010-0051076 · May 31, 2010 · national
Continuity (2)
Division 13700867
Related Publication 20170143849A1 · May 25, 2017